BioNxt Solutions Inc. (OTCMKTS:BNXTF – Get Free Report)’s share price was down 3.1% during mid-day trading on Friday . The stock traded as low as $0.3451 and last traded at $0.3642. Approximately 2,100 shares were traded during mid-day trading, a decline of 47% from the average daily volume of 3,971 shares. The stock had previously closed at $0.3759.
BioNxt Solutions Trading Down 3.1%
The stock has a market capitalization of $44.61 million, a P/E ratio of -9.11 and a beta of 0.82. The company has a fifty day simple moving average of $0.46 and a two-hundred day simple moving average of $0.54.
BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) last posted its quarterly earnings results on Friday, November 28th. The company reported ($0.01) earnings per share for the quarter. The company had revenue of $0.01 million for the quarter.
About BioNxt Solutions
BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.
BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.
Recommended Stories
- Five stocks we like better than BioNxt Solutions
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- URGENT: Trump Just Triggered AI’s Biggest Disruption Yet
- Wall Street Alert: Buy AES
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
